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Introduction: Dioxins are environmental and persistent pollutants mostly emitted from combustion facilities (e.g.
waste incinerators, metal and cement industries). Known to be endocrine disrupting chemicals, dioxins are suspected
to increase breast cancer (BC) risk. Although diet is considered the primary source of dioxin exposure, no previous
study has been published on dietary dioxin exposure in relation to BC risk. We aimed to assess dietary dioxin exposure
among women from the E3N cohort and estimate BC risk associated with this exposure.
Methods: The study included 63,830 women from the E3N cohort who completed a diet history questionnaire (DHQ)
in 1993 and were followed until 2008. Dietary dioxin exposure was estimated by combining consumption data from
the E3N DHQ and food dioxin contamination data from a French national monitoring program. Hazard ratios (HR) and
95% confidence intervals (CI) were estimated by Cox models adjusted for BC risk factors.
Results: Mean dietary dioxin exposure was estimated at 1.3 ± 0.4 pg/kg body weight (BW)/day. A 0.4 pg/kg BW/d
increase in dioxin intake was not associated with overall BC risk (HR = 1.00; 95% CI: 0.96, 1.05). A significant decrease in risk
of estrogen receptor negative (ER-)/progesterone receptor negative (PR-) tumors was observed among post-menopausal
women in the upper quartile of estimated dioxin intake (HR for Q4 vs. Q1: 0.65; 95% CI: 0.45, 0.96; P for trend across
quartiles = 0.0463).
Conclusions: Overall, no association between estimated dietary dioxin exposure and BC risk was found among E3N
women. Further studies should include both dietary and environmental exposures to determine whether low-dose dioxin
exposure is associated with BC risk.Introduction
Polychlorinated dibenzo-p-dioxins (PCDD) and poly-
chlorinated dibenzofurans (PCDF), together defined as
dioxins, are toxic environmental by-products resulting
from the incomplete combustion of chlorinated sub-
stances from metal and cement industries, waste inciner-
ators or domestic activities. Because they are highly
lipophilic and persistent pollutants, dioxins can contam-
inate the food chain and accumulate in adipose tissues
[1]. Therefore, in the general population, diet is considered* Correspondence: beatrice.fervers@lyon.unicancer.fr
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unless otherwise stated.one of the main sources of exposure to dioxins [1-3]. Most
of the studies assessing dietary dioxin exposure concluded
that food from animal origin rich in fat such as dairy prod-
ucts and meat, and seafood are the most contaminated
foods. Because contribution of specific food groups to
dioxin exposure depends on their consumption, main
contributors might differ between populations due to
different dietary patterns.
Dioxins are known to be endocrine disrupting chemi-
cals [4] and suspected to play a role in the increase of
hormone-related cancer incidence such as breast cancer.
The 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the
most toxic congener and has been classified as carcino-
genic to humans by the International Agency for Research
on Cancer (IARC) and the US Environmental Protection
Agency (US EPA) [5,6].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cancer risk associated with dioxin exposure, and there
have been inconsistent results. Among the cohort of res-
idents exposed to TCDD following the Seveso accident
(Italy, 1976), no increased breast cancer risk was ob-
served among women living in the areas most exposed
to TCDD [7,8]. Nevertheless, elevated serum TCDD
levels measured in Seveso women who lived in the two
most contaminated zones were associated with increased
breast cancer risk in a first analysis conducted in 2002
[9]. However, this was not confirmed with longer follow
up of the same population [10]. Studies conducted
among cohorts of workers exposed to dioxins during
production of herbicides showed higher breast cancer
mortality in these populations (reviewed in [11,12]).
Other studies also reported elevated breast cancer
mortality [13] and increased breast cancer risk [14] in
cohorts of community residents exposed to dioxins
emitted by industrial facilities. However in a French
case-control study, a decrease in breast cancer risk was
observed among older women living near a municipal
solid-waste incinerator (MSWI) and most exposed to
dioxins [15].
To our knowledge no epidemiological study has ex-
plored the association between dioxin exposure through
diet and breast cancer risk. Therefore, our study aimed
to assess dietary dioxin exposure among women from
the French E3N prospective cohort and estimate breast
cancer risk associated with this exposure.
Methods
The E3N cohort study
The E3N (Etude Epidémiologique auprès de femmes de la
Mutuelle Générale de l'Education Nationale) study is an
ongoing prospective cohort involving 98,995 French fe-
male volunteers, born between 1925 and 1950 and mem-
bers of a national teachers’ health insurance plan [16]. The
E3N study was initiated to identify female cancer risk fac-
tors, especially dietary, hormonal and reproductive factors.
The study began in 1990 when participants returned the
first questionnaire and gave signed informed consent.
Since then women have completed self-administered
questionnaires sent by mail every 2 to 3 years about their
lifestyle, health status and medical history. The E3N study
protocol was approved by the French National Commis-
sion for Data Protection and Privacy.
Study population
Women included in our study population were participants
of the E3N study, who had completed the E3N diet history
questionnaire (DHQ) in 1993 and were followed until June
2008. Among the 74,522 women with dietary data, women
having under- or over-reported their consumption, that is,
those in the bottom and top 1% of the energy intake tobasal metabolic rate ratio computed on the basis of age,
height and weight, were excluded (n = 1,360). In addition,
we excluded women who reported cancer diagnosis (except
non-melanoma skin cancer) before completing the E3N
DHQ (n = 4,705) along with those who developed in situ
breast cancer (n = 483) and those for whom follow-up in-
formation was unavailable (n = 822). We further excluded
3,302 women with missing body weight (BW) in 1993 and
20 women who had never menstruated. Finally 63,830
women were included in our study population.Breast cancer cases
From the third self-administered questionnaire to the
ninth, data on health status and medical history of women,
including cancer occurrence, were collected and updated.
A total of 3,465 women reported primary invasive breast
cancer between 1993 and 2008 and 92% of them were con-
firmed by pathology reports. Information on estrogen re-
ceptor (ER) and progesterone receptor (PR) were extracted
from these reports, and invasive breast cancer cases were
classified as ER+/PR+ (n = 1,596), ER+/PR- (n = 561) or
ER-/PR- (n = 414). Because of the small number of cases,
the ER-/PR+ invasive breast cancers were not considered in
the analyses (n = 107). Because the proportion of false-
positive self-reported breast cancer in the E3N cohort
was <5%, breast cancers not confirmed by pathology re-
port (n = 285) were considered as cases. Deaths were
identified through family contact or from insurance
files, and causes of death were obtained from the French
National Service on Causes of Death [17].Assessment of dietary dioxin exposure
Consumption data
Dietary data were collected from a validated self-
administered DHQ, specifically developed for the assess-
ment of the previous year's usual diet of the E3N popu-
lation and sent in 1993 [18]. The E3N DHQ covered the
daily consumption of 208 food items by collecting food
frequencies and portion sizes for 8 meals and snacks
during the day. The questionnaire comprised both a
quantitative and a qualitative part. In the quantitative
part, women were asked to indicate the frequency of
consumption and to estimate portion sizes of food
groups, food items and beverages. Portion sizes were es-
timated with a validated photo booklet [19]. The qualita-
tive part provided detailed information on women’s
relative consumption frequency of specific food items
within one of the food groups of the first part. Further-
more, a food composition table was generated from a
French national database [20], providing information on
fat content of most of the food items assessed in the
E3N DHQ.
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An assessment of the level of food contamination by di-
oxins (PCDDs and PCDFs) in France was published in
2000 by the French High Council for Public Health
(Conseil Supérieur d’Hygiène Publique de France (CSHPF))
[21]. These contamination data were based on food sam-
ples collected from 1996 to 1998 which was the closest
period to the E3N DHQ. Food samples analyzed in this
report (n = 444) included dairy products, meats, seafood
products, cereal products, fruits and vegetables, eggs and
fats (Additional file 1: Table S1). They were collected
from monitoring and control plans mostly performed by
the Directorate for food of the French Agriculture minis-
try (DGAL) and the General Directorate for Competition
Policy, Consumer Affairs and Fraud Control (DGCCRF).
Measurements of dioxin contamination in these sam-
ples were performed in one single laboratory (Carso
Laboratory, Lyon, France) with a certified method
using high-resolution gas chromatography/high-reso-
lution mass spectrometry (HRGC/HRMS). Dioxin con-
centrations were calculated with the lower-bound
method, assuming that non-detected congeners were
equal to zero. Results were expressed in pg TEQ/g lipid
weight, except for foods from vegetal origin (that is, cereal
products and fruit and vegetables) for which results were
expressed in pg TEQ/g fresh weight.
Exposure assessment
Dietary dioxin exposure in our study was estimated for
each woman, by combining consumption data from the
E3N DHQ and lipid levels from the food composition
table developed by the E3N team with food dioxins con-
tamination data from the CSHPF report (Additional file
1: Table S1), using the following formulas recommended
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where Ei is the dietary dioxin exposure for the woman i
(in pg TEQ/kg BW/day), Ci,k is the consumption of the
food k by the woman i (in g/day), Fk is the proportion of
lipids of the food k (in %), Lk is the average dioxin con-
tamination of the food k (in pg TEQ/g lipid weight, see
equation 1), Pk is the average dioxin contamination of
the food k (in pg TEQ/g fresh weight, see equation 2)
and BWi is the body weight of the woman i (in kg) re-
ported in the E3N questionnaire of 1993.The intake of PCDDs and PCDFs was calculated in
toxic equivalent (TEQ) using toxic equivalence factors
(TEF) first developed by the North Atlantic Treaty
Organization (NATO) in 1989 [23]. In 2001, the WHO
established a dioxin-tolerable daily intake of 2.3 pg
TEQ/kg BW/day [24,25].
Statistical analysis
Participants contributed person-years of follow up from
the date they completed the E3N DHQ to the date of
diagnosis of primary invasive breast cancer, date of
death, date of return of the ninth questionnaire or June
2008, whichever occurred first. Estimated dietary dioxin
exposure was categorized according to quartiles of its
distribution in the study population. Baseline character-
istics of the participants were described by quartiles of
estimated dietary dioxin exposure using mean and
standard deviation (SD) for quantitative variables and
frequency and percentage for qualitative variables.
Hazard ratios (HR) and 95% confidence intervals (CI)
for breast cancer were estimated for an increase of
0.43 pg TEQ/kg BW/day (that is, 1 SD) and for quartiles
of estimated dietary dioxin exposure with first quartile
used as reference, using Cox proportional hazard models,
stratified by 5-year-interval birth cohorts (from 1925 to
1950). Women’s age was used as the timescale. To evalu-
ate potential dose-response associations, tests for linear
trend across quartiles were derived from the Wald test
of the models with the semi-continuous variable. All
models were adjusted for known breast cancer risk fac-
tors and potential confounders: height (cm), body mass
index (BMI) before and after menopause (cut off: 25,
30 kg/m2; considered as a time-dependent variable), total
energy intake excluding alcohol (kcal/day), alcohol intake
(cut off: 0, 6.9 g/day), education (undergraduate/post-
graduate with a 1- to 4-year university degree/postgradu-
ate with a 5+ year university degree), physical activity at
baseline (cut off: 34, 46, 62 metabolic equivalent task-
hour per week (MET-h/w)), smoking status (never
smoked/ex-smoker/current smoker; time-dependent vari-
able), age at menarche (cut off: 12, 14 years), previous
use of oral contraceptives (never/ever), previous use of
progestin before menopause (never/ever), menopausal
status combined with use of menopausal hormone treat-
ment (MHT) (premenopausal/postmenopausal non-using
of MHT/postmenopausal using of MHT; time-dependent
variable), age at menopause (cut off: 47, 54 years, among
postmenopausal women only), age at first full-term preg-
nancy combined with number of live births (no child/≤2
children and age at first birth <30 years/≤2 children and
age at first birth ≥30 years/≥3 children), breastfeeding
(never/ever), previous family history of breast cancer
(yes/no), previous history of personal benign breast
disease (yes/no; time-dependent variable), previous
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adjustments for food group consumption (including fruit
and vegetable, fish and seafood, dairy products or total
dietary flavonoid intake) were made. All adjustment vari-
ables had less than 5% missing data that were replaced by
their modal or median value in the population. Informa-
tion on estimated dietary dioxin exposure was available
for all women of the study population.
We also estimated risk of invasive breast cancer ac-
cording to hormone receptor status (ER/PR). We ex-
cluded cases for whom joint hormone-receptor status
(n = 787) was missing from the corresponding analyses.
Interactions between BMI and estimated dietary dioxin
exposure were tested among premenopausal and post-
menopausal women in relation to breast cancer risk be-
cause of opposite associations between BMI and risk of
breast cancer before and after menopause [26] and the
storage of dioxins in adipose tissues. Analyses were also
stratified by weight change during follow up (cut
points >−2 kg/5 years; >2 kg/5 years) and dietary pat-
terns ("Western" vs. "Healthy" patterns [27]). Because
of previously observed negative associations, we stud-
ied interactions between estimated dietary dioxin ex-
posure and smoking status, and breastfeeding [28,29]
while interaction between estimated dietary dioxin expos-
ure and alcohol consumption was studied due to potential
positive association [30]. All tests for interaction were de-
rived from the likelihood-ratio test comparing the models
with and without an interaction term. Sensitivity analysis
was performed, excluding breast cancer cases diagnosed
less than 2 years after completing the E3N DHQ, to elim-
inate possible preclinical tumors. All P-values were two-
sided and the significance level was set at 0.05. We used
the SAS statistical software version 9.3 (SAS Institute Inc.,
Cary, NC, USA) for data analysis.
Results
We analyzed data from 63,830 women with a median fol-
low up of 14.9 years, corresponding to 888,505 person-Table 1 Contribution of food groups to estimated dietary dio
Consumption (g/day),
Food groups mean ± SD
Dairy products 341.0 ± 417.7
Fruit and vegetables 724.8 ± 288.5
Meat 122.2 ± 55.2
Seafood 38.0 ± 27.2
Eggs 26.4 ± 20.4
Cereal products 247.7 ± 108.8
Added fats 25.2 ± 11.7
Total 1,525.3 ± 417.7years and during which 3,465 incident invasive breast can-
cers occurred. The food groups most consumed were fruit
and vegetables (mean ± SD: 724.8 ± 288.5 g/d), dairy prod-
ucts (341.0 ± 200.1 g/d) and cereal products (247.7 ±
108.8 g/d, Table 1). Fish and seafood were less frequently
consumed (38.0 ± 27.2 g/d). The average level of dietary di-
oxin exposure was estimated at 1.3 ± 0.4 pg TEQ/kg BW/d
(range: 0.1 to 5.7 pg TEQ/kg BW/d) and 2.7% of women
exceeded the 2.3 pg TEQ/kg BW/d toxicity threshold
established by the WHO [24,25]. The highest contributors
to the total estimated dietary dioxin exposure were dairy
products (33.3%), fruit and vegetables (22.1%), meat (18.8%)
and fish and seafood (15.6%), while the contribution from
eggs (5.5%), cereal products (3.6%) and added fats (1.2%)
was low.
Higher estimated dietary dioxin exposure was seen in
younger women and in those with higher energy intake,
higher alcohol consumption, lower pre- and postmeno-
pausal BMI, and in women with 1 or 2 children before
30 years, with a personal history of benign breast disease
and those who had breastfed at least one of their chil-
dren (Table 2).
Table 3 shows HRs associated with estimated dietary di-
oxin exposure among overall participants and according to
hormone receptor status (ER/PR). An increase of 0.43 pg
TEQ/kg BW/d in the intake of dioxins was not associated
with risk of invasive breast cancer risk among overall par-
ticipants, neither in the univariable nor in the multivariable
models: HR = 1.01 (0.99, 1.03) and HR = 1.00 (0.96, 1.05),
respectively. There was no statistically significant linear
trend between quartiles of estimated dietary dioxin expos-
ure and breast cancer risk (P for trend = 0.9405). There
was also no association between estimated dietary dioxin
exposure and ER+/PR+ or ER+/PR- breast cancer risk.
However a borderline statistically significant decrease in
ER-/PR- breast cancer risk was observed across quartiles
of estimated dietary dioxin exposure (HR for Q1 vs.
Q4: 0.72, 95% CI: 0.50, 1.02; P for trend across quar






0.428 ± 0.223 33.3
0.284 ± 0.116 22.1
0.242 ± 0.184 18.8
0.200 ± 0.173 15.6
0.071 ± 0.054 5.5
0.046 ± 0.020 3.6
0.015 ± 0.013 1.2
1.285 ± 0.428 100.0
Table 2 Main baseline characteristics of the study population according to quartiles of estimated dietary dioxin
exposure, E3N cohort, 1993 (n = 63,830)
Dietary dioxin exposure (pg/kg body weight/day)
<0.98 [0.98, 1.23] [1.23, 1.52] ≥1.52
Age (years), mean ± SD 53.5 ± 6.8 53.0 ± 6.7 52.5 ± 6.5 51.9 ± 6.3
Energy intake (kcal/day), mean ± SD 1710.3 ± 391.7 2003.6 ± 405.5 2231.6 ± 437.0 2580.8 ± 513.4
Smoking status, n (%)
Non-smoker 8672 (54.3) 8611 (54.0) 8614 (54.0) 8429 (52.8)
Former smoker 5102 (32.0) 5259 (33.0) 5243 (32.9) 5288 (33.1)
Smoker 2184 (13.7) 2087 (13.1) 2101 (13.2) 2240 (14.0)
Combined menopausal status, MHTa use and BMIb, n (%)
Premenopausal
BMI <25 kg/m2 4797 (73.7) 5665 (82.2) 6362 (87.1) 7143 (91.5)
BMI ≥25 kg/m2 1715 (26.3) 1227 (17.8) 942 (12.9) 667 (8.5)
Postmenopausal not using MHT
BMI <25 kg/m2 2572 (58.7) 2679 (70.4) 2715 (76.5) 2692 (82.8)
BMI ≥25 kg/m2 1813 (41.4) 1129 (29.7) 833 (23.5) 560 (17.2)
Postmenopausal using MHT
BMI <25 kg/m2 3526 (69.7) 4127 (78.5) 7261 (83.5) 4344 (88.7)
BMI ≥25 kg/m2 1535 (30.3) 1130 (21.5) 845 (16.6) 551 (11.3)
Parity and age at first birth, n (%)
No child 2035 (12.8) 1890 (11.8) 1793 (11.2) 1685 (10.6)
≤2 children <30 years old 7661 (48.0) 7913 (49.6) 8076 (50.6) 8393 (52.6)
≤2 children ≥30 years old 1527 (9.6) 1402 (8.8) 1464 (9.2) 1378 (8.6)
≥3 children 4735 (29.7) 4752 (29.8) 4625 (29.0) 4501 (28.2)
Breastfeeding, n (%)
Ever 8916 (55.9) 9234 (55.9) 9321 (58.4) 9365 (58.7)
Never 7042 (44.1) 6723 (42.1) 6637 (41.6) 6592 (41.3)
Alcohol intake, n (%)
0 g/day 2636 (16.5) 2021 (12.7) 1685 (10.6) 1356 (8.5)
<6.9 g/day 6688 (41.9) 6354 (39.8) 5897 (37.0) 5181 (32.5)
≥6.9 g/day 6634 (41.6) 7582 (47.5) 8376 (52.5) 9420 (59.0)
Personal history of benign breast disease, n (%)
Yes 4292 (26.9) 4570 (28.6) 4907 (30.8) 4949 (31.0)
No 11666 (73.1) 11387 (71.4) 11051 (69.3) 11008 (69.0)
aMHT, menopausal hormone treatment; bBMI, body mass index.
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breast cancer risk (HR for Q4 vs. Q1: 0.65, 95% CI: 0.45,
0.96; P for trend across quartiles = 0.0463) (Table 4).
Adjusting for fruit and vegetable consumption, total
dietary flavonoid intake, or any other food groups, did
not change the results (data not shown). There was no
significant interaction between BMI and estimated diet-
ary dioxin exposure among pre- and postmenopausal
women in relation to invasive breast cancer risk. There
was no effect modification by smoking, alcohol consump-
tion, dietary patterns, gain or loss of weight during follow
up and breastfeeding, and there was no associationbetween estimated dietary dioxin exposure and breast can-
cer risk in any above-defined subgroups (Additional file 1:
Table S2). Our results did not change when excluding
breast cancer cases diagnosed less than 2 years after inclu-
sion (data not shown).
Discussion
To our knowledge, this study is the first to assess breast
cancer risk associated with dietary dioxin exposure.
Among women from the E3N prospective cohort, we
did not observe any increase of breast cancer risk associ-
ated with estimated dietary dioxin exposure. Among
Table 3 Hazard ratios for invasive breast cancer for increased intake of 0.43 pg/kg body weight/day, according to
quartiles of estimated dietary dioxin exposure and hormone receptor status (n = 63,830), 1993 to 2008
Dietary dioxin exposure (pg/kg body weight/day)
Populationsc /0.43 <0.98 (ref) [0.98, 1.23] [1.23, 1.52] ≥1.52 P-trend
Cases, n 3465 880 853 848 884
HR (95% CI)a 1.01 (0.99, 1.03) 1.00 0.97 (0.88, 1.06) 0.96 (0.88, 1.06) 1.02 (0.92, 1.11) 0.4181
HR (95% CI)b 1.00 (0.96, 1.05) 1.00 0.94 (0.86, 1.04) 0.93 (0.83, 1.03) 0.96 (0.85, 1.09) 0.9405
ER+/PR+d
Cases, n 1596 410 388 389 409
HR (95% CI)a 1.02 (0.98, 1.07) 1.00 0.94 (0.82, 1.08) 0.95 (0.82, 1.09) 1.00 (0.88, 1.15) 0.5328
HR (95% CI)b 1.00 (0.93, 1.07) 1.00 0.91 (0.79, 1.06) 0.90 (0.77, 1.05) 0.94 (0.78, 1.12) 0.9678
ER+/PR-d
Cases, n 561 131 146 137 147
HR (95% CI)a 1.04 (0.96, 1.13) 1.00 1.12 (0.88, 1.41) 1.05 (0.83, 1.34) 1.14 (0.90, 1.45) 0.3565
HR (95% CI)b 1.04 (0.93, 1.17) 1.00 1.10 (0.86, 1.41) 1.03 (0.79, 1.35) 1.14 (0.84, 1.54) 0.4571
ER-/PR-d
Cases, n 414 109 103 104 98
HR (95% CI)a 0.96 (0.87, 1.06) 1.00 0.93 (0.71, 1.22) 0.94 (0.72, 1.23) 0.89 (0.67, 1.16) 0.4221
HR (95% CI)b 0.88 (0.77, 1.01) 1.00 0.86 (0.65, 1.13) 0.81 (0.60, 1.10) 0.72 (0.50, 1.02) 0.0629
aAge-adjusted models; badjusted for age, height, body mass index, energy intake, education, physical activity, smoking status, menopausal status combined with
use of menopausal hormone treatment, alcohol intake, age at menarche, use of oral contraceptives, use of progestin, age at menopause, age at first full-term pregnancy
and number of live births, breastfeeding, family history of breast cancer, history of personal benign breast disease and mammography; cER-/PR+ invasive breast cancer
risk was not analyzed due to small number of cases (n = 107); dn = 787 invasive breast cancer cases with missing hormone receptor status. HR, hazard ratio.
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served between estimated dioxin intake and ER-/PR-
breast cancer risk.
Our estimation of an average dioxin intake of 1.3 pg
TEQ/kg BW/d is of the same order of magnitude or
lower than in other studies. In a monitoring program
conducted in 1996 to 1998 in the general French popu-
lation and using the same dioxin contamination data as
in our study, mean dietary dioxin exposure was also esti-
mated at 1.3 pg TEQ/kg BW/d [21]. At the same period
in Europe, estimated dietary dioxin exposure of the gen-
eral population varied between 1.0 pg TEQ/kg BW/d
(Germany) and 3.5 pg TEQ/kg BW/d (Spain) [31-34]. In
the US, dietary dioxin exposure was estimated between
0.3 and 3.2 pg TEQ/kg BW/d [35]. Dairy products and
seafood were consistently identified across studies as be-
ing the main food contributors to dioxin exposure
[21,32,34]. However, because food contribution depends
on dietary habits, some studies (including ours) showed
an additional important contribution of cereal products
and fruit and vegetables [31]. These foods, although little
contaminated by dioxins, are highly consumed by some
populations, and their contribution to overall dioxin in-
take must thus be considered. However, most previous
studies focused on dioxin intake from foods known to
be the most contaminated by dioxins and did not consider
dioxin intake from consumption of foods from vegetal ori-
gin. This is likely to result in an underestimation of theintake of dioxins, as concluded in a validation study of a
dietary questionnaire developed for the assessment of diet-
ary dioxin exposure [36].
Previous studies investigating the association between
breast cancer and dioxin exposure (environmental, acci-
dental and occupational) mostly reported a weak in-
crease in the risk of breast cancer [9,14] or the mortality
rates of breast cancer [11-13]. Our results are not con-
sistent with those studies, probably because they have
focused on populations exposed accidentally, occupa-
tionally or living near emitting sources of dioxins, that
is, exposed to high levels of dioxins, whereas our study
population was exposed to low levels of dioxins. More-
over, among the Seveso Women's Health Study (SWHS)
[9], the results were obtained for a different exposure
window than women from the E3N study, as the SWHS
women were aged 0 to 40 at the time of exposure (1976)
whereas in 1993, almost half of the women of our study
population were postmenopausal.
Our results suggest that exposure to dioxins in the low
range observed in our study may be associated with a
decreased risk of hormone-independent (ER-/PR-) breast
cancer, especially after menopause. Inverse associations
between endocrine disrupting chemicals and ER- breast
cancer risk have been found previously. Raaschou-
Nielsen et al. found a lower risk associated with higher
adipose tissue concentrations of dioxin-like organochlo-
rines in postmenopausal women [37]. Gammon et al.
Table 4 Hazard ratios for pre- and postmenopausal breast cancer risk for increased intake of 0.43 pg/kg body weight/
day, according to quartiles of estimated dietary dioxin exposure (n = 63,830), 1993 to 2008
Dietary dioxin exposure (pg/kg body weight/day)
Populations /0.43 <0.98 (ref) [0.98, 1.23] [1.23, 1.52] ≥1.52 P-trend
Premenopausal womenc
Cases, n 446 104 105 117 120
HR (95% CI)a 1.03 (0.94, 1.13) 1.00 0.93 (0.71, 1.22) 0.96 (0.74, 1.25) 0.94 (0.73, 1.23) 0.5705
HR (95% CI)b 0.98 (0.87, 1.12) 1.00 0.84 (0.63, 1.11) 0.83 (0.62, 1.11) 0.77 (0.54, 1.08) 0.7873
Postmenopausal womend
Cases, n 3019 775 749 731 764
HR (95% CI)a 1.01 (0.98, 1.05) 1.00 0.97 (0.88, 1.08) 0.96 (0.87, 1.06) 1.03 (0.93, 1.14) 0.5134
HR (95% CI)b 0.98 (0.93, 1.03) 1.00 0.94 (0.84, 1.04) 0.90 (0.80, 1.01) 0.93 (0.82, 1.06) 0.3827
ER+/PR+e
Cases, n 1365 354 336 325 350
HR (95% CI)a 1.02 (0.96, 1.07) 1.00 0.96 (0.82, 1.11) 0.94 (0.81, 1.09) 1.03 (0.89, 1.20) 0.5837
HR (95% CI)b 0.97 (0.90, 1.04) 1.00 0.91 (0.78, 1.06) 0.86 (0.73, 1.02) 0.91 (0.75, 1.10) 0.4193
ER+/PR-e
N cases 513 117 136 125 135
HR (95% CI)a 1.05 (0.96, 1.14) 1.00 1.17 (0.92, 1.50) 1.09 (0.85, 1.40) 1.20 (0.93, 1.53) 0.2780
HR (95% CI)b 1.05 (0.93, 1.18) 1.00 1.16 (0.89, 1.49) 1.07 (0.81, 1.41) 1.19 (0.86, 1.63) 0.4341
ER-/PR-e
N cases 359 98 91 89 81
HR (95% CI)a 0.95 (0.85, 1.06) 1.00 0.93 (0.70, 1.23) 0.91 (0.68, 1.21) 0.84 (0.62, 1.13) 0.3261
HR (95% CI)b 0.86 (0.74, 1.00) 1.00 0.84 (0.63, 1.13) 0.77 (0.56, 1.07) 0.65 (0.45, 0.96) 0.0463
aAge-adjusted models; badjusted for age, height, body mass index, energy intake, education, physical activity, smoking status, menopausal status combined with
use of menopausal hormone treatment, alcohol intake, age at menarche, use of oral contraceptives, use of progestin, age at menopause, age at first full-term
pregnancy and number of live births, breastfeeding, family history of breast cancer, history of personal benign breast disease and mammography; cresults for premenopausal
breast cancer risk according to hormone receptor status were not presented due to the small number of cases; dER-/PR+ postmenopausal invasive breast cancer risk was not
analyzed due to small number of cases (n = 73); en = 709 postmenopausal invasive breast cancer cases with missing hormone receptor status. HR, hazard ratio.
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women with serum levels of PCBs in the highest tertile
compared to the lowest [38]. Some studies investigating
breast cancer risk in relation to dioxin exposure also
suggested a decreased breast cancer risk. A French
registry-based case-control study conducted near a
MSWI showed a decreased risk of invasive breast cancer
among women aged over 60 years and highly exposed,
compared to non-exposed women, although these re-
sults could be explained by confounding, because there
was no adjustment on breast cancer risk factors or other
potential confounders other than age and place of resi-
dence [15]. A small decrease in breast cancer risk was
also observed among women exposed during the Seveso
accident and followed between 1977 and 1986, although
not statistically significant [7]. However, the authors of
these studies did not stratify on tumor hormone recep-
tor status. Our findings may also be supported by ex-
perimental evidence on the role of dioxins in promotion
or inhibition of mammary tumor formation. TCDD has
been shown to operate in animals and humans throughbinding to the aryl hydrocarbon receptor (AhR, [5]).
Some studies have described an antiproliferative action
of TCDD in ER- breast cancer cell lines through AhR-
dependent [39,40] or AhR-independent pathways [41].
These observations were complemented by animal stud-
ies demonstrating that TCDD inhibits the proliferation
of cells from the mammary gland and mammary tumor
formation [42,43]. In a recent review of the literature on
the role of AhR in carcinogenesis, Safe et al. highlighted
the fact that the effect of TCDD may vary according to
the target organ as well as windows of exposure [44].
For example, animal studies have demonstrated that pre-
natal TCDD exposure increased susceptibility to
carcinogen-induced mammary tumor formation, while
exposure during pregnancy delayed mammary tumor
formation. Women of our study population were on
average aged 57.2 ± 6.6 years old at inclusion in 1993.
Therefore, we were not able to investigate the associ-
ation of breast cancer risk with estimated dietary dioxin
exposure during other windows of exposure such as pre-
natal periods or pregnancy.
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Strengths of our study include the prospective design,
the large size of the study population and number of
breast cancer cases, a long follow-up that provides a
large latency period for potential cancer occurrence, ad-
justment for most known breast cancer risk factors up-
dated throughout follow-up, and validated dietary data.
The participation rate which is still high 18 years after
the start of the E3N study (≥75% at each follow-up ques-
tionnaire) and the low percentage of missing data attests
of the quality of the information collected. Because our
statistical models were adjusted for several individual
breast cancer risk factors, it is unlikely that residual
confounding changes our risk estimates. Moreover, we
analyzed the potential confounding effect of flavonoid
intake. Flavonoids are dietary phytochemicals that have
been suggested to protect against dioxin toxicity [45]
and to play a role in breast cancer prevention [46,47];
adjustment for total dietary flavonoid intake did not
change our results.
Nevertheless, our study has some limitations. First, to de-
termine dietary dioxin exposure, we used consumption
data obtained through a semi-quantitative diet history
questionnaire. DHQ are often used for their applicability to
a large number of participants. However, as DHQ are self-
administered questionnaires on habitual food consumption
over the past 12 months, we cannot exclude some inaccur-
acy of consumption data and a non-differential bias due to
the desire of conformity to social norms. Nevertheless, the
potential lack of precision has been minimized by the
collection of food frequency for each food item and the
estimation of portion sizes through a photo-booklet.
Moreover, both the dietary questionnaire and photo-
booklet have been validated [18,19].
Second, the food contamination data by dioxins came
from the first French national monitoring program, which
aimed to assess dioxin levels of foods sampled between
1996 and 1998 [21]. Because the authors did not achieve an
exhaustive sampling plan, the data may not be representa-
tive of the dioxin contamination of food in France for that
period. However, because of the large number of samples
(n = 444), the coverage of all major food contributors of di-
oxin intake and the fact that those data were the closest to
the period of the E3N DHQ administration, we can assume
that they accurately reflect the contamination of food in
1993. We combined the consumption data with the con-
tamination data using standardized formulas recommended
by the WHO [22]. However, for some food items of the
E3N DHQ, no contamination data were reported in the
CSHPF study; therefore we assigned to each of these items
the average contamination of the food group to which it
belonged (see Additional file 1: Table S1 for an example).
Also, we could not consider the source of the food con-
sumed, that is, women living and consuming foodproduced near a dioxin emitting source may consume
foods more contaminated than average. This could have
led to an underestimation of the exposure for those women
and to misclassification bias, although non differential so
the risk would be potentially drawn toward 1. The esti-
mated dietary dioxin exposure may not reflect the total ex-
posure to dioxins of the E3N women. We cannot eliminate
the contribution of exposure from environmental sources,
even if its contribution remains probably minor compared
to that of food. In contrast, because most women from the
E3N cohort are teachers or from affiliated occupations, we
can assume the occupational dioxin exposure to be negli-
gible and homogeneous among study participants.
Our estimation of the dietary dioxin exposure cannot
be extrapolated to the French general population. In-
deed, the intake of dioxins through the diet depends on
the relative intake of foods of high or low levels of di-
oxin contamination and their quantity consumed (for in-
stance, our population has a higher consumption of fruit
and vegetables than generally observed). Moreover, we
can expect a healthy participation effect in our cohort,
as it is composed of volunteers with a high level of edu-
cation and health consciousness. This could result in a
possible underrepresentation of high fat (so high dioxin)
consumptions; however this should not have biased our
results.
Conclusion
Among women from the E3N prospective cohort, esti-
mated dietary dioxin exposure was not associated with
breast cancer risk. Further studies should include both
dietary and non-dietary (environmental) exposures as
well as different windows of exposure (prenatal, preg-
nancy periods) in order to further investigate the com-
plex association between low-dose dioxin exposure and
hormone receptor-defined breast cancer risk.
Additional file
Additional file 1: Table S1. Dioxin contamination and lipids proportion
of food items from the E3N diet history questionnaire of 1993. Table S2.
Hazards ratios (HR) for invasive breast cancer in subgroups defined by body
mass index, weight change, dietary patterns and breastfeeding (n = 63,830),
1993 to 2008.
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